Chandramohan Bathula
AstraZeneca India Private Limited, Jubilant Biosys Ltd, University of Cape Town Faculty of Science, Shiv Nadar University
0000-0001-7723-3660
About
Dr. Chandramohan Bathula has obtained B.Sc. From Kakatiya university and M.Sc. from Osmania university India. After completing M.Sc. Dr. Bathula joined in Jubilant Biosys India Pvt Ltd (Drug discovery center) India in 2010 . Thereafter, he moved to Astra Zeneca India Pvt Ltd. India in 2012. He obtained Ph.D. in 2017 from Shiv Nadar University India under the supervision of Dr. Subhabrata Sen. His thesis work comprises Identifying novel chemotypes against Breast Cancer: Design, Synthesis and Biological evaluation. Dr. Bathula has authored/co-authored 12 peer reviewed journal articles. In July 2017 he has joined medicinal chemistry group of Drug Discovery and Development Center (H3D), University of Cape Town as a Post-Doctoral Research Fellow and is working with the Celgene team to develop novel anti-tuberculosis drugs.
Employment
-
AstraZeneca India Private Limited Assistant Research Scientist-22012 - 2013
-
Jubilant Biosys Ltd Jr. Research Associate2010 - 2012
Education
-
University of Cape Town Faculty of Science Postdoctoral Fellow2017 - Present
-
Shiv Nadar University PhD2013 - 2017
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Bioisosteric modification of known fucosidase inhibitors to discover a novel inhibitor of α-l-fucosidase Save
- Identification of Leishmania donovani Topoisomerase 1 inhibitors via intuitive scaffold hopping and bioisosteric modification of known Top 1 inhibitors Save
- ChemInform Abstract: Synthesis of Novel 5-Arylidenethiazolidinones with Apoptotic Properties via a Three Component Reaction Using Piperidine as a Bifunctional Reagent. Save
- Synthesis of novel 5-arylidenethiazolidinones with apoptotic properties via a three component reaction using piperidine as a bifunctional reagent Save
- Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity Save
- Design, synthesis and biological evaluation of small molecules as potent glucosidase inhibitors Save
- Diversity oriented synthesis for novel anti-malarials Save
- Diverse synthesis of natural product inspired fused and spiro-heterocyclic scaffolds via ring distortion and ring construction strategies Save
- Substituted furopyridinediones as novel inhibitors of α-glucosidase Save
- ChemInform Abstract: Diversity-Oriented Asymmetric Synthesis Save